Co-designing primary and secondary outcome measures for an international phase 3 trial of surgical de-escalation in vulvar cancer through a consumer workshop

Abstract Background Consumer involvement in clinical trials has developed to be a critical driver of feasibility and real-world translation. In gynaecological oncology, patient and clinician priorities can differ, particularly regarding acceptable risks and treatment burden. Vulvar cancer treatment...

Descrición completa

Detalles Bibliográficos

Principais autores:	Lauren Angel, Monika Janda, Andrew Martin, Brianna Armstrong, Merran Williams, Nicola Du Thaler, Emma Wild, Mary Li, Andreas Obermair
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2026-06-01
Series:	Research Involvement and Engagement
Assuntos:	Patient engagement Lived experience Shared decision-making Gynaecological oncology Lymphoedema Treatment burden
Acceso en liña:	https://doi.org/10.1186/s40900-026-00902-8
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!